EUVIMEDEUVIMED entdecken
Crossref

Real world data on the use of neoadjuvant chemo-immunotherapy in early triple-negative breast cancer

A.B. Rodríguez García, J. Sánchez A, B. Walbaum, E. Seguí, Y. Torralba, O. Martínez-Sáez, F. Brasó, F. Schettini, I. García-Fructuoso, R. Gómez-Bravo, T. Pascual, B. Adamo und 7 weitere

European Journal of Cancer · 2026-03 · 237 · 116504

DOI: 10.1016/j.ejca.2026.116504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von A.B. Rodríguez García und 18 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

García, A. R., A, J. S., Walbaum, B., Seguí, E., Torralba, Y., Martínez-Sáez, O., Brasó, F., Schettini, F., García-Fructuoso, I., Gómez-Bravo, R., Pascual, T., Adamo, B., González, M., Carcelero, E., Prat, A., Vidal, M., Muñoz, M., Bergamino, M., & Martinelli, G. (2026). Real world data on the use of neoadjuvant chemo-immunotherapy in early triple-negative breast cancer. European Journal of Cancer, 237, 116504. https://doi.org/10.1016/j.ejca.2026.116504

Vancouver

García AR, A JS, Walbaum B, Seguí E, Torralba Y, Martínez-Sáez O, et al. Real world data on the use of neoadjuvant chemo-immunotherapy in early triple-negative breast cancer. European Journal of Cancer. 2026;237:116504. doi:10.1016/j.ejca.2026.116504

BibTeX
@article{Garca2026,
  author = {García, A.B. Rodríguez and A, J. Sánchez and Walbaum, B. and Seguí, E. and Torralba, Y. and Martínez-Sáez, O. and Brasó, F. and Schettini, F. and García-Fructuoso, I. and Gómez-Bravo, R. and Pascual, T. and Adamo, B. and González, M. and Carcelero, E. and Prat, A. and Vidal, M. and Muñoz, M. and Bergamino, M. and Martinelli, G.},
  title = {Real world data on the use of neoadjuvant chemo-immunotherapy in early triple-negative breast cancer},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {237},
  pages = {116504},
  doi = {10.1016/j.ejca.2026.116504}
}
Kostenlos starten →